NEW YORK, Oct. 8, 2014 /PRNewswire/ -- Five years after creating a pharmaceutical & health care vertical in its business portfolio, the 9.8 Group Inc., a marketing communications holding, continues to receive recognition for its market impact, having been honored in two categories at the 2014 PM360 Trailblazer Awards.
PM360, a monthly magazine for marketing decision makers in the pharmaceutical, biotech and medical device industries, has awarded Prime Access, a subsidiary of the 9.8 Group, with the PM360 Trailblazer Initiative Award as a Multicultural Campaign Silver Winner for its 2013 Hypertension US Hispanic Campaign. The award was an addition to PM360 recognizing Steven Millerman, CEO of Prime Access, with the PM360 Trailblazer Marketer of the Year Award.
For the 9.8 Group, the win adds to a growing list of marketing awards in the pharmaceutical industry, including 2013 American Advertising Federation's Mosaic Award for Best Multiethnic Media Usage, and the 2012 and 2013 DTC National Gold Advertising Awards for Best Multicultural Campaign and Best Branded Print Campaign. For Prime Access, the dual win arrives on the heels of more than 25 pharmaceutical brand engagements in only the last two years, since it became a 9.8 Group portfolio company. The PM360 recognition further highlights the industry's increased focus on the rapidly growing multicultural consumer market, as well as the agency's unique positioning at the intersection of health care and multicultural markets.
"The 9.8 Group is focused on driving innovation and growth across its portfolio businesses by working in verticals and providing them with financial backing and strategic methodology to deliver success. To see Prime Access honored in this way underscores its commitment to excellence and the strength of our approach," said Givi Topchishvili, Founder and CEO of the 9.8 Group.
The Hypertension US Hispanic Campaign is representative of the agency's efforts. Utilizing extensive research findings, Prime Access created a branded campaign for a hypertension medication with reach and resonance across gender, country of origin, and geographical region. The campaign was one of only a handful in 2013 to target the US Hispanic audience with an original creative effort, as opposed to work adapted from a general market strategy and creative platform. The effort drove brand growth and increased awareness of high blood pressure within the US Hispanic community. Steven Millerman was honored as Marketer of the Year, which recognizes the year's game-changing team in pharmaceutical, biotech, or medical device marketing.
"We are honored to shine a spotlight on the most innovative and creative initiatives from the past year," says Anna Stashower, CEO and Publisher of PM360. "All of our winners faced fierce competition as we received an overwhelming number of submissions, but each demonstrated a remarkable achievement through their strategy, execution and, ultimately, value to the industry."
Winners were honored during a special reception at Gotham Hall on September 18th, 2014, and will be featured in the October issue of PM360.
About 9.8 Group
The 9.8 Group is a strategic holding company with a portfolio of specialty firms and branded solutions in technology, media, healthcare, and communications. Throughout its history, the 9.8 Group has successfully capitalized on the most promising market sectors and provided its partners with the opportunity to share the success, while remaining socially responsible and sustainable. It's primary focus is in the biotech, travel and market entry verticals.
About Prime Access
With over 20 years of success, Prime Access is the only full-service advertising and marketing communications company at the intersection of health care and multicultural markets.
Find out how Prime Access can be a Cultural Catalyst for your brand at www.prime-access.com.
SOURCE 9.8 Group
Share this article